Mia Petljak
Mia Petljak
Broad Institute of MIT and Harvard
Verified email at broadinstitute.org - Homepage
Title
Cited by
Cited by
Year
POT1 loss-of-function variants predispose to familial melanoma
CD Robles-Espinoza, M Harland, AJ Ramsay, LG Aoude, V Quesada, ...
Nature genetics 46 (5), 478-481, 2014
2862014
Genome sequencing of normal cells reveals developmental lineages and mutational processes
S Behjati, M Huch, R van Boxtel, W Karthaus, DC Wedge, AU Tamuri, ...
Nature 513 (7518), 422-425, 2014
2592014
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
S Nik-Zainal, DC Wedge, LB Alexandrov, M Petljak, AP Butler, N Bolli, ...
Nature genetics 46 (5), 487, 2014
2342014
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ...
Nature 543 (7647), 714-718, 2017
1622017
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
M Petljak, LB Alexandrov, JS Brammeld, S Price, DC Wedge, ...
Cell 176 (6), 1282-1294. e20, 2019
1202019
Understanding mutagenesis through delineation of mutational signatures in human cancer
M Petljak, LB Alexandrov
Carcinogenesis 37 (6), 531-540, 2016
782016
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
F Maura, M Petljak, M Lionetti, I Cifola, W Liang, E Pinatel, LB Alexandrov, ...
Leukemia 32 (4), 1043-1047, 2018
452018
Germline TERT promoter mutations are rare in familial melanoma
M Harland, M Petljak, CD Robles-Espinoza, Z Ding, NA Gruis, ...
Familial cancer 15 (1), 139-144, 2016
392016
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
JS Brammeld, M Petljak, I Martincorena, SP Williams, LG Alonso, ...
Genome research 27 (4), 613-625, 2017
222017
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion
A Tovy, JM Reyes, MC Gundry, L Brunetti, H Lee-Six, M Petljak, HJ Park, ...
Cell Stem Cell, 2020
32020
Molecular Origins of APOBEC-Associated Mutations in Cancer
M Petljak, J Maciejowski
DNA Repair, 102905, 2020
32020
Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage
A Tovy, HJ Park, JM Reyes, A Guzman, RE Rau, A Jeffries, M Jonnathan, ...
Blood 132 (Supplement 1), 173-173, 2018
2018
Biological and Prognostic Impact of Apobec-Induced Mutations in the Spectrum of Plasma Cell Dyscrasias
F Maura, M Petljak, M Lionetti, I Cifola, W Liang, E Pinatel, L Alexadrov, ...
Blood 130 (Supplement 1), 1771-1771, 2017
2017
The apobec mutational activity in multiple myeloma: from diagnosis to cell lines
F Maura, M Petljak, S Minvielle, R Szalat, M Lionetti, I Cifola, W Liang, ...
Congress of the Italian-Society-of-Hematology 102 (suppl. 3), 124-124, 2017
2017
THE 2016 CARCINOGENESIS AWARD WINNERS
M Petljak, LB Alexandrov, M Karin, D Dhar
Carcinogenesis 37 (6), 2016
2016
POT1 mutations predispose to familial melanoma
CD Robles-Espinoza, M Harland, AJ Ramsay, LG Aoude, V Quesada, ...
Cancer Research 74 (23 Supplement), 20-20, 2014
2014
Newly identified melanoma susceptibility genes in families highlight the importance of the telomere in melanoma carcinogenesis and prognosis
J Newton-Bishop, M Harland, CD Robles-Espinoza, M Iles, M Petljak, ...
King’s Research Portal
YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ...
The system can't perform the operation now. Try again later.
Articles 1–18